Advanced Biomed, Inc. (ADVB)
4.91
-0.23
(-4.47%)
USD |
NASDAQ |
Oct 15, 14:23
Advanced Biomed Enterprise Value : 8.514M for Oct. 14, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 14, 2026 | 8.514M |
| October 13, 2026 | 8.546M |
| October 12, 2026 | 8.736M |
| October 09, 2026 | 8.794M |
| October 08, 2026 | 10.13M |
| October 07, 2026 | 10.28M |
| October 06, 2026 | 10.56M |
| October 05, 2026 | 10.50M |
| October 02, 2026 | 11.14M |
| October 01, 2026 | 11.44M |
| September 30, 2026 | 10.31M |
| September 29, 2026 | 10.46M |
| September 28, 2026 | 11.14M |
| September 25, 2026 | 10.56M |
| September 24, 2026 | 10.45M |
| September 23, 2026 | 10.46M |
| September 22, 2026 | 10.56M |
| September 21, 2026 | 10.71M |
| September 18, 2026 | 10.83M |
| September 17, 2026 | 12.12M |
| September 16, 2026 | 12.78M |
| September 15, 2026 | 13.37M |
| September 14, 2026 | 12.88M |
| September 11, 2026 | 13.55M |
| September 10, 2026 | 14.64M |
| Date | Value |
|---|---|
| September 09, 2026 | 14.06M |
| September 08, 2026 | 14.86M |
| September 04, 2026 | 15.44M |
| September 03, 2026 | 15.55M |
| September 02, 2026 | 16.16M |
| September 01, 2026 | 17.27M |
| August 31, 2026 | 15.63M |
| August 28, 2026 | 16.05M |
| August 27, 2026 | 15.83M |
| August 26, 2026 | 15.29M |
| August 25, 2026 | 15.19M |
| August 24, 2026 | 13.27M |
| August 21, 2026 | 13.47M |
| August 20, 2026 | 13.55M |
| August 19, 2026 | 13.82M |
| August 18, 2026 | 14.43M |
| August 17, 2026 | 13.62M |
| August 14, 2026 | 14.81M |
| August 13, 2026 | 14.20M |
| August 12, 2026 | 12.58M |
| August 11, 2026 | 12.86M |
| August 10, 2026 | 13.09M |
| August 07, 2026 | 10.55M |
| August 06, 2026 | 12.31M |
| August 05, 2026 | 13.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| SBC Medical Group Holdings, Inc. | 416.17M |
| Abbott Laboratories | 205.83B |
| Acme United Corp. | 268.76M |
| Align Technology, Inc. | 9.309B |
| AngioDynamics, Inc. | 445.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.3959M |
| Revenue (Quarterly) | 0.004M |
| Total Expenses (Quarterly) | 0.3999M |
| EPS Diluted (Quarterly) | -0.2603 |
| Profit Margin (Quarterly) | -9.90K% |
| Earnings Yield | -1.63% |
| Normalized Earnings Yield | -1.629 |